Immunotherapy-Chemo combo before surgery shows promise for advanced ovarian cancer
NCT ID NCT07673835
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This phase 2 trial tests whether combining two immunotherapy drugs (iparomlimab and tuvonralimab) with standard chemotherapy before surgery can improve outcomes for people with advanced ovarian cancer. Participants receive 3-4 cycles of the combination, followed by surgery to remove visible tumors, then more chemo after surgery. The study aims to see if this approach extends the time before the cancer progresses. It enrolls 49 adults with stage III or IV ovarian, fallopian tube, or primary peritoneal cancer who are candidates for surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- iparomlimab and tuvonralimab (immunotherapy) plus platinum-based chemotherapy
- What this could lead to
- If successful, this combination could become a new standard neoadjuvant treatment for advanced ovarian cancer, potentially delaying disease progression.
- What could go wrong
- This is a small, early-phase trial with no control group, so results may not be definitive. Immunotherapy can cause immune-related side effects, and not all patients may respond.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPITHELIAL OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Obstetrics and Gynecology Hospital of Fudan University
Shanghai, 201101, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Metabolic clues: could your Body's energy use predict ovarian cancer outcomes?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can heated chemotherapy improve ovarian cancer outcomes?
- Can a new PET tracer light up hidden cancers?
- A Two-for-One surgery: could tube removal during Weight-Loss surgery slash ovarian cancer risk?
- Can AI spot ovarian cancer on CT scans before It's too late?